Cerebral inflammatory response during and after cardiac surgery

Area of Science:

• Cardiovascular Surgery
• Neuroscience
• Immunology

Background:

• Neurological dysfunction frequently occurs after cardiac surgery involving cardiopulmonary bypass (CPB).
• CPB-induced cerebral ischemia may trigger neuronal damage and inflammation, releasing specific markers and cytokines.
• Investigating arterial-cerebral venous gradients helps pinpoint the origin of these released substances.

Purpose of the Study:

• To determine the origin of neuronal-ischaemic markers and inflammatory cytokines during and after CPB.
• To quantify arterial-cerebral venous concentration gradients of these markers and cytokines.
• To assess the role of cerebral inflammation in CPB-associated neurological changes.

Main Methods:

• Twenty-five patients undergoing coronary artery bypass grafting were studied.
• Plasma concentrations of neuron-specific enolase, S-100beta protein, IL-6, IL-8, and IL-10 were measured.
• Blood samples were collected from arterial and cerebral venous sites at various time points: pre-surgery, during CPB, post-CPB, and up to 6 hours post-ICU admission.

Main Results:

• No detectable arterial-cerebral venous concentration gradients for neuron-specific enolase, S-100beta, IL-6, IL-8, or IL-10 were found.
• S-100beta and neuron-specific enolase levels significantly increased during hypothermic CPB compared to baseline.
• Elevated levels of neuronal-ischaemic markers and cytokines persisted after CPB termination without returning to baseline.

Conclusions:

• Despite overall increases in neuronal markers and cytokines, no cerebral release was detected via venous gradients.
• The observed elevations are likely due to systemic circulation sources rather than a primary cerebral inflammatory response.
• CPB-associated increases in these markers may not solely originate from the brain.